Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
J Neonatal Perinatal Med ; 14(4): 475-484, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33843703

RESUMEN

BACKGROUND: Pregnant mothers with opioid dependency commonly receive maintenance treatment of opioid (OMT), either as buprenorphine (BMT) or methadone maintenance treatment (MMT). We investigated, whether OMT adversely affects standardized neonatal anthropometric outcomes and whether BMT is potentially safer than MMT in this regard. METHODS: Retrospective chart review of mother infant dyad, with and without OMT. Infant's absolute and standardized (z-score) anthropometric outcomes at birth were first compared, between OMT and control group (negative meconium drug screen), and then between BMT and MMT group. These outcomes were also compared between infants who did or did not require treatment after birth for neonatal abstinence syndrome (NAS). RESULT: A total of 1479 participants with MDS were included [Control = 1251; OMT = 228 (MMT = 181; BMT = 47)]. Both the z-scores of birth weight (BW) and head circumference (HC) was lower in OMT group (p < 0.001). Among the OMT group, GA at delivery was slightly higher in the BMT group (p = 0.05). There was an inverse correlation between maternal dose at the time of delivery and anthropometric z-scores in the BMT group, mainly in female infants (BW: p = 0.006; HC: p = 0.003). Furthermore, In BMT group, infants with lower HC were more likely to require treatment for NAS (p = 0.01). CONCLUSION: HC and BW when comparing Z-scores were not different between MMT and BMT. High maternal dosing of buprenorphine is associated with lower BW and HC Z-scores but dose effect is not seen with methadone. In addition, there seems to be an association between NAS severity and HC, especially in the BMT group.


Asunto(s)
Buprenorfina , Complicaciones del Embarazo , Analgésicos Opioides/efectos adversos , Peso al Nacer , Buprenorfina/uso terapéutico , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Metadona , Tratamiento de Sustitución de Opiáceos , Embarazo , Complicaciones del Embarazo/tratamiento farmacológico , Estudios Retrospectivos
2.
Plant Biol (Stuttg) ; 18 Suppl 1: 13-21, 2016 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-26307426

RESUMEN

Quercus ilex L. seedlings were exposed in open-top chambers for one growing season to three levels of ozone (O3 ): charcoal filtered air, non-filtered air supplemented with +30% or +74% ambient air O3 . Key functional parameters related to photosynthetic performance and stomatal density were measured to evaluate the response mechanisms of Q. ilex to chronic O3 exposure, clarifying how ecophysiological traits are modulated during the season in an ozone-enriched environment. Dark respiration showed an early response to O3 exposure, increasing approximately 45% relative to charcoal-filtered air in both O3 enriched treatments. However, at the end of the growing season, maximum rate of assimilation (Amax ) and stomatal conductance (gs ) showed a decline (-13% and -36%, for Amax and gs , respectively) only in plants under higher O3 levels. Photosystem I functionality supported the capacity of Q. ilex to cope with oxidative stress by adjusting the energy flow partitioning inside the photosystems. The response to O3 was also characterised by increased stomatal density in both O3 enriched treatments relative to controls. Our results suggest that in order to improve the reliability of metrics for O3 risk assessment, the seasonal changes in the response of gs and photosynthetic machinery to O3 stress should be considered.


Asunto(s)
Ozono/efectos adversos , Fotosíntesis/efectos de los fármacos , Transpiración de Plantas/efectos de los fármacos , Quercus/fisiología , Ambiente , Estrés Oxidativo , Hojas de la Planta/efectos de los fármacos , Hojas de la Planta/fisiología , Estomas de Plantas/efectos de los fármacos , Estomas de Plantas/fisiología , Quercus/efectos de los fármacos , Reproducibilidad de los Resultados , Estaciones del Año , Plantones/efectos de los fármacos , Plantones/fisiología
3.
Domest Anim Endocrinol ; 41(4): 195-206, 2011 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-21885231

RESUMEN

In the present study, buffalo granulosa cells were cultured under serum-free conditions and characterized to study the changes in gene expression associated with the transition of granulosa cells from estrogen- to progesterone-secreting phenotype. The cells were cultured in vitro under completely serum-free conditions for 8 d. Gene expression and hormone analysis showed that on day 4 granulosa cells exhibit FSH responsiveness with preovulatory phenotype having highest CYP19 gene expression and 17ß-estradiol production, whereas a significant increase in transcript abundance of STAR, CYP11, and HSD3B genes accompanied with an increase in progesterone production was observed on day 8. Cells treated with LH on day 4 followed by gene expression analysis at 1, 2, 4, 6, 18, and 24 h showed significant increase in transcripts of LH-responsive genes. In conclusion, culture condition used in the present study showed that granulosa cells were FSH responsive and attained attributes of granulosa cells of dominant follicles at day 4 with highest CYP19 and LHR gene expression beyond which they acquired the ability to luteinize and thus were more LH responsive. In addition, after LH treatment, analysis of early LH-responsive genes (EGR2, RUNX1, and NR4A1) on day 4 showed that granulosa cells at this stage in culture exhibits phenotype similar to that of preovulatory follicles before LH surge in vivo and corresponds to the in vivo transition of well-orchestrated gene expression profile after LH surge. The characterized culture conditions represent a suitable in vitro model for analysis of genes involved in terminal differentiation of granulosa cells from FSH- to LH-responsive phenotype during folliculogenesis in buffalo.


Asunto(s)
Búfalos/genética , Búfalos/metabolismo , Hormona Folículo Estimulante/farmacología , Regulación de la Expresión Génica/fisiología , Células de la Granulosa/metabolismo , Hormona Luteinizante/farmacología , Animales , Técnicas de Cultivo de Célula , Proliferación Celular , Medio de Cultivo Libre de Suero , Relación Dosis-Respuesta a Droga , Femenino , Hormona Folículo Estimulante/administración & dosificación , Perfilación de la Expresión Génica , Células de la Granulosa/citología , Factor I del Crecimiento Similar a la Insulina/administración & dosificación , Factor I del Crecimiento Similar a la Insulina/farmacología , Hormona Luteinizante/administración & dosificación
4.
Hepatology ; 45(1): 97-101, 2007 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-17187417

RESUMEN

UNLABELLED: The role of antivirals in patients with acute viral hepatitis B (AVH-B) has not been evaluated in controlled trials. The aim of this study was to evaluate the efficacy of lamivudine in patients with AVH-B. AVH-B patients with serum bilirubin of more than 5 mg/dL were randomized to receive either 100 mg of lamivudine daily for 3 months (group 1, n = 31) or placebo (group 2, n = 40). Patients were considered to have severe AVH-B if they fulfilled 2 of 3 criteria: (1) hepatic encephalopathy; (2) serum bilirubin > or = 10.0 mg/dL; and (3) international normalized ratio (INR) > or = 1.6. At week 4, HBV DNA levels were significantly lower (P = 0.037) in group 1 (median: 3.6721 log copies/mL) than group 2 (median: 4.2721 log copies/mL). Thereafter, HBV DNA levels were comparable in the 2 groups. The improvement in serum bilirubin, ALT, and INR values was similar in the 2 groups. Twenty-two patients (71%) in group 1 and 25 patients (62.5%) in group 2 had severe AVH-B. Results were similar when patients with severe AVH-B were analyzed separately. After 12 and 18 months, 93.5% and 92.5%, respectively, of patients in the lamivudine group and 96.7% and 97.5%, respectively, of patients in the placebo group lost HBsAg. There were no deaths in either group. After 1 year, 21 patients (67.7%) in group 1 and 34 patients (85%) in group 2 developed protective anti-HBs titers (P = 0.096). All HBeAg-positive patients in both groups lost e antigen and anti-HBe developed in 71% and 87.5% of patients in groups 1 and 2, respectively (P = 0.132). CONCLUSION: Though lamivudine causes a greater decrease in levels of HBV DNA, it does not cause significantly greater biochemical and clinical improvement as compared to placebo in patients with acute hepatitis B.


Asunto(s)
Hepatitis B/tratamiento farmacológico , Hepatitis B/inmunología , Inmunocompetencia/inmunología , Lamivudine/uso terapéutico , Inhibidores de la Transcriptasa Inversa/uso terapéutico , Enfermedad Aguda , Adolescente , Adulto , Anciano , Bilirrubina/sangre , Niño , ADN Viral/metabolismo , Femenino , Hepatitis B/metabolismo , Antígenos e de la Hepatitis B/sangre , Virus de la Hepatitis B/genética , Virus de la Hepatitis B/inmunología , Humanos , Lamivudine/efectos adversos , Masculino , Persona de Mediana Edad , Inhibidores de la Transcriptasa Inversa/efectos adversos , Resultado del Tratamiento
5.
Indian J Gastroenterol ; 23(5): 189-90, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15599008

RESUMEN

We report our experience with endoscopic management of 3 men (aged 62, 63 and 65 years) with duodenal diaphragm disease following NSAID use for 5-15 years. In the first patient a 24 F through-the-scope balloon dilatation was attempted but failed; he subsequently underwent gastro-jejunostomy. The other two patients subsequently underwent radial incisions of the web with mixed cutting and coagulation current using a standard 5 F sphincterotome.


Asunto(s)
Antiinflamatorios no Esteroideos/efectos adversos , Obstrucción Duodenal/inducido químicamente , Obstrucción Duodenal/cirugía , Duodenoscopía/métodos , Anciano , Antiinflamatorios no Esteroideos/uso terapéutico , Diafragma/patología , Relación Dosis-Respuesta a Droga , Estudios de Seguimiento , Humanos , Cuidados a Largo Plazo , Masculino , Persona de Mediana Edad , Procedimientos Quirúrgicos Mínimamente Invasivos/métodos , Enfermedades Reumáticas/diagnóstico , Enfermedades Reumáticas/tratamiento farmacológico , Medición de Riesgo , Muestreo , Resultado del Tratamiento
6.
J Assoc Physicians India ; 48(8): 834-5, 2000 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-11273482

RESUMEN

With the advent of magnetic resonance imaging, brain lesions associated with Japanese encephalitis are increasingly being recognized and correlated with movement disorder. Bilateral haemorrhagic thalamic infarcts on MRI, suggested as a characteristic finding in Japanese encephalitis were conspicuous by their absence in this case report of Japanese encephalitis.


Asunto(s)
Encefalitis Japonesa/diagnóstico , Imagen por Resonancia Magnética , Enfermedades Neuromusculares/diagnóstico , Adolescente , Encéfalo/patología , Infarto Cerebral/diagnóstico , Diagnóstico Diferencial , Dominancia Cerebral/fisiología , Humanos , Masculino , Enfermedades Talámicas/diagnóstico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA